IR-Med Inc.
IRME · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $4,425 | $34,204 | $33,198 | $37,502 |
| - Cash | $63 | $51 | $129 | $392 |
| + Debt | $250 | $189 | $157 | $155 |
| Enterprise Value | $4,612 | $34,342 | $33,226 | $37,265 |
| Revenue | $0 | $0 | $26 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$4 | -$3 | $13 | -$4 |
| % Margin | – | – | 50% | – |
| EBITDA | -$282 | -$250 | -$272 | -$597 |
| % Margin | – | – | -1,046.2% | – |
| Net Income | -$701 | -$773 | -$278 | -$598 |
| % Margin | – | – | -1,069.2% | – |
| EPS Diluted | -0.01 | -0.011 | -0.004 | -0.009 |
| % Growth | 12% | -176.9% | 54.1% | – |
| Operating Cash Flow | -$71 | -$110 | -$261 | -$395 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$71 | -$110 | -$261 | -$395 |